Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the acceptance of three abstracts for a poster...

Related Keywords

San Diego ,California ,United States ,Monica Moreno ,Marissa Herrman ,Jackie Wilde ,Nasdaq ,Assay Development ,Adicet Bio Inc ,Society For Immunotherapy Of Cancer ,Adicet Bio ,Annual Meeting ,Quantitative Detection ,Universal Assay ,Cell Therapies ,Abstract Number ,Ligand Expressing Cancers ,Cytokine Signaling Checkpoint ,Anti Tumor Activity ,Beibei Ding ,Markets ,